18F-FDG PET/CT in sarcoidosis management: Review and report of 20 cases

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 8, 2008, Pages 1537-1543

  Braun, Jean Jacques ^a,b   Kessler, Romain ^a   Constantinesco, André ^a   Imperiale, Alessio ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b HÔPITAL CIVIL   (France)

Author keywords

18F FDG PET CT; 67Ga scintigraphy; Response to therapy; Sarcoidosis

Indexed keywords

FLUCIS; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; PREDNISOLONE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG UPTAKE; EXTRATHORACIC SARCOIDOSIS; FEMALE; HUMAN; LACRIMAL GLAND; LARYNX; LIVER; LYMPHADENOPATHY; MALE; PARANASAL SINUS; PATIENT COMPLIANCE; PHARYNX; POSITRON EMISSION TOMOGRAPHY; REMISSION; RETROSPECTIVE STUDY; SALIVARY GLAND; SARCOIDOSIS; SCINTIGRAPHY; SKIN; STOMACH; THORACIC SARCOIDOSIS; CASE REPORT; IMAGE SUBTRACTION; METHODOLOGY; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 48149084959     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0770-9     Document Type: Article

References (25)

1. RP Baughman EE Lower RM du Bois 2003 Sarcoidosis Lancet. 361 1111 1118
2. HR Schwartzbauer TA Tami 2003 Ear, nose and throat manifestations of sarcoidosis Otolaryngol Clin N Am. 36 673 684
3. JJ Braun A Gentine G Pauli 2004 Sinonasal sarcoidosis: review and report of fifteen cases Laryngoscope. 114 1960 1963
4. FM Aubart M Ouayoun M Brauner P Attali M Kambouchner D Valeyre 2006 Sinonasal involvement in sarcoidosis Medicine. 85 365 371
5. SS Gambhir J Czernin J Schwimmer DH Silverman RE Coleman ME Phelps 2001 A tabulated summary of the FDG PET literature J Nucl Med. 42 1S 93S
6. AS Teirstein J Machac O Almeida P Lu M Padilla MC Iannuzzic 2007 Results of 188 whole-body FDG PET scans in 137 patients with sarcoidosis Chest. 132 1949 1953
7. 18F-FDG PET and PET/CT in fever of unknown origin J Nucl Med. 48 35 45
8. K Kaira T Ishizuka N Yanagitani N Sunaga T Hisada M Mori 2007 Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis Clin Nucl Med. 32 114 116
9. BD Nguyen 2007 F-18 FDG PET imaging of disseminated sarcoidosis Clin Nucl Med. 32 53 54
10. 67Ga scintigraphy in patients with sarcoidosis J Nucl Med. 47 1571 1576
11. H Klech H Kohn F Kummer A Mostbeck 1982 Assessment of activity in sarcoidosis Chest. 82 732 738
12. A Alavi N Gupta JL Alberini M Hickeson LE Adam P Bhargava 2002 Positron emission tomography imaging in non malignant thoracic disorders Semin Nucl Med. 32 293 321
13. A Alavi CA Buchpiguel A Loessner 1994 Is there a role for FDG PET imaging in the management of patients with sarcoidosis J Nucl Med. 35 1650 1652
14. LH Brudin SO Valind CG Rhodes CF Pantin M Sweatman T Jones 1994 Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography Eur J Nucl Med. 21 297 305
15. A Alavi HI Palevsky 1992 Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis J Nucl Med. 33 751 755
16. RP Baughman M Fernandez CH Bosken J Mantil P Hurtubise 1984 Comparison of gallium-67 scanning, bronchoalveolar lavage and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis: predicting response to therapy Am Rev Respir Dis. 129 676 681
17. EC Lawrence RB Teague MS Gottlieb SG Jhingran J Lieberman 1983 Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis Am J Med. 74 747 756
18. G El-Haddad H Zhuang N Gupta A Alavi 2004 Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders Semin Nucl Med. 34 313 329
19. T Koyama H Ueda K Togashi S Umeoka M Kataoka S Nagai 2004 Radiologic manifestations of sarcoidosis in various organs RadioGraphics. 24 87 104
20. TA Loehrl TL Smith 2001 Inflammatory and granulomatous lesions of the larynx and pharynx Am J Med. 111 113 117
21. C Love MB Tomas GG Tronco CJ Palestro 2005 FDG PET of infection and inflammation RadioGraphics. 25 1357 1368
22. JM Chang HJ Lee JM Goo HY Lee JJ Lee JK Chung 2006 False positive and false negative FDG-PET scans in various thoracic diseases Korean J Radiol. 7 57 69
23. Y Xiu JQ Yu A Cheng R Kumar A Alavi H Zhunang 2005 Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy Clin Nucl Med. 30 193 195
24. JA Vento M Arici RP Spencer R Sood 2004 F-18 FDG PET: mottled splenomegaly with remission of symptoms after splenectomy in sarcoidosis Clin Nucl Med. 29 103 104
25. K Kaira N Oriuchi Y Otani N Yanagitani N Sunaga T Hisada 2007 Diagnostic usefulness of fluorine-18-a-methyltyrosine positron emission tomography in combination with F-fluorodeoxyglucose in sarcoidosis patients Chest. 131 1019 1027